This research was funded by the Office of Naval Research through Core funds provided to the Naval Research Laboratory.

<ol>
	<li>Avila-Calderon, E. D., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Roles+of+bacterial+membrane+vesicles.">Roles of bacterial membrane vesicles.</a> Arch. Microbiol. 197, 1-10 (2015).</li><li>Kulp, A., Kuehn, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biological+functions+and+biogenesis+of+secreted+bacterial+outer+membrane+vesicles.">Biological functions and biogenesis of secreted bacterial outer membrane vesicles.</a> Annu. Rev. Microbiol. 64, 163-184 (2010).</li><li>Beveridge, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Structures+of+Gram+negative+cell+walls+and+their+derived+membrane+vesicles.">Structures of Gram negative cell walls and their derived membrane vesicles.</a> J. Bacteriol. 181, 4725-4733 (1999).</li><li>Kulkarni, H. M., Jagannadham, M. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Biogenesis+and+multifaceted+roles+of+outer+membrane+vesicles+from+Gram-negative+bacteria.">Biogenesis and multifaceted roles of outer membrane vesicles from Gram-negative bacteria.</a> Microbiology. 160, 2109-2121 (2014).</li><li>Ellis, T. N., Kuehn, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Virulence+and+immunomodulatory+roles+of+bacterial+outer+membrane+vesicles.">Virulence and immunomodulatory roles of bacterial outer membrane vesicles.</a> Microbiol. Mol. Biol. Rev. 74, 81-94 (2010).</li><li>Berleman, J., Auer, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+role+of+bacterial+outer+membrane+vesicles+for+intra-+and+interspecies+delivery.">The role of bacterial outer membrane vesicles for intra- and interspecies delivery.</a> Environ. Microbiol. 15, 347-354 (2013).</li><li>Alves, N. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Bacterial+nanobioreactors-directing+enzyme+packaging+into+bacterial+outer+membrane+vesicles.">Bacterial nanobioreactors-directing enzyme packaging into bacterial outer membrane vesicles.</a> ACS Appl. Mater. Interfaces. 7, 24963-24972 (2015).</li><li>Kim, J. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Engineered+bacterial+outer+membrane+vesicles+with+enhanced+functionality.">Engineered bacterial outer membrane vesicles with enhanced functionality.</a> J. Mol. Biol. 380, 51-66 (2008).</li><li>Haurat, M. F., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Selective+sorting+of+cargo+proteins+into+bacterial+membrane+vesicles.">Selective sorting of cargo proteins into bacterial membrane vesicles.</a> J. Biol. Chem. 286, 1269-1276 (2011).</li><li>Kesty, N. C., Kuehn, M. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Incorporation+of+heterologous+outer+membrane+and+periplasmic+proteins+into+Escherichia+coli+outer+membrane+vesicles.">Incorporation of heterologous outer membrane and periplasmic proteins into Escherichia coli outer membrane vesicles.</a> J. Biol. Chem. 279, 2069-2076 (2003).</li><li>Zakeri, B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Peptide+tag+forming+a+rapid+covalent+bond+to+a+protein,+through+engineering+a+bacterial+adhesion.">Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesion.</a> Proc. Natl. Acad. Sci. U. S. A. 109, e690-e697 (2012).</li><li>Li, L., Fierer, J. O., Rapoport, T. A., Howarth, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Structural+analysis+and+optimization+of+the+covalent+association+between+SpyCatcher+and+a+peptide+tag.">Structural analysis and optimization of the covalent association between SpyCatcher and a peptide tag.</a> J. Mol. Biol. 426, 309-317 (2014).</li><li>Dumas, D. P., Durst, H. D., Landis, W. G., Raushel, F. M., Wild, J. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Inactivation+of+organophosphorus+nerve+agents+by+the+phophotriesterase+from+Pseudomonas-Diminuta.">Inactivation of organophosphorus nerve agents by the phophotriesterase from Pseudomonas-Diminuta.</a> Arch. Biochem. Biophys. 277, 155-159 (1990).</li><li>Bigley, A. N., Raushel, F. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Catalytic+mechanisms+for+phosphotriesterases.">Catalytic mechanisms for phosphotriesterases.</a> Biochimica et Biochim. Biophys. Acta, Proteins Proteomics. 1834, 443-453 (2013).</li><li>Minton, N. A., Murray, V. S. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+review+of+organo-phosphate+poisoning.">A review of organo-phosphate poisoning.</a> Med. Toxicol. Adverse Drug Exper. 3, 350-375 (1988).</li><li>Bigley, A. N., Xu, C., Henderson, T. J., Harvey, S. P., Raushel, F. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Enzymatic+neutralization+of+the+chemical+warfare+agent+VX:+Evolution+of+phosphotriesterase+for+phosphorothiolate+hydrolysis.">Enzymatic neutralization of the chemical warfare agent VX: Evolution of phosphotriesterase for phosphorothiolate hydrolysis.</a> J. Am. Chem. Soc. 135, 10426-10432 (2013).</li><li>Chatterjee, S. N., Chaudhuri, K. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Gram-negative+bacteria:+the+cell+membranes.">Gram-negative bacteria: the cell membranes.</a> Outer Membrane Vesicles of Bacteria. SpringerBriefs in Microbiology. , 15-34 (2012).</li><li>Wang, Y. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+function+of+OmpA+in+Escherichia+coli.">The function of OmpA in Escherichia coli.</a> Biochem. Biophys. Res. Commun. 292, 396-401 (2002).</li><li>Danoff, E. J., Fleming, K. G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+soluble,+periplasmic+domain+of+OmpA+folds+as+an+independent+unit+and+displays+chaperone+activity+by+reducing+the+self-association+propensity+of+the+unfolded+OmpA+transmembrane+beta-barrel.">The soluble, periplasmic domain of OmpA folds as an independent unit and displays chaperone activity by reducing the self-association propensity of the unfolded OmpA transmembrane beta-barrel.</a> Biophys. Chem. 159, 194-204 (2011).</li><li>Alves, N. J., Kline, J. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Comparative+study+on+the+inhibition+of+plasmin+and+delta-plasmin+via+benzamidine+derivatives.">Comparative study on the inhibition of plasmin and delta-plasmin via benzamidine derivatives.</a> Biochem. Biophys. Res. Commun. 457, 358-362 (2015).</li><li>Wang, W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lyophilization+and+development+of+solid+protein+pharmaceuticals.">Lyophilization and development of solid protein pharmaceuticals.</a> Int. J. Pharm. 203, 1-60 (2000).</li><li>Goormaghtigh, E., Scarborough, G. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Density-based+separation+of+liposomes+by+glycerol+gradient+centrifugation.">Density-based separation of liposomes by glycerol gradient centrifugation.</a> Anal. Biochem. 159, 122-131 (1986).</li><li>Alves, N. J., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Functionalized+liposome+purification+via+Liposome+Extruder+Purification+(LEP).">Functionalized liposome purification via Liposome Extruder Purification (LEP).</a> Analyst. 138, 4746-4751 (2013).</li><li>Mayer, L. D., StOnge, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Determination+of+free+and+liposome-associated+doxorubicin+and+vincristine+levels+in+plasma+under+equilibrium+conditions+employing+ultrafiltration+techniques.">Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.</a> Anal. Biochem. 232, 149-157 (1995).</li><li>Blakeley, B. D., Chapman, A. M., McNaughton, B. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Split-superpositive+GFP+reassembly+is+a+fast,+efficient,+and+robust+method+for+detecting+protein-protein+interactions+in+vivo.">Split-superpositive GFP reassembly is a fast, efficient, and robust method for detecting protein-protein interactions in vivo.</a> Mol. BioSyst. 8 (2036), (2012).</li><li>De Crescenzo, G., Litowski, J. R., Hodges, R. S., O'Connor-McCourt, M. D. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Real-time+monitoring+of+the+interacation+of+two-stranded+de+novo+designed+coiled-coils:+effect+of+chain+length+on+the+kinetic+and+thermodynamic+constants+of+binding.">Real-time monitoring of the interacation of two-stranded de novo designed coiled-coils: effect of chain length on the kinetic and thermodynamic constants of binding.</a> Biochemistry. 42, 1754-1763 (2003).</li><li>Charalambous, A., Antoniades, I., Christodoulou, N., Skourides, P. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Split-Intein+for+simultaneous+site-specific+conjugation+of+quantum+dots+to+multiple+protein+targets+in+vivo.">Split-Intein for simultaneous site-specific conjugation of quantum dots to multiple protein targets in vivo.</a> J. Nanobiotechnol. 9, 1-14 (2011).</li><li>Lee, E. Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Global+proteomic+profiling+of+native+outer+membrane+vesicles+derived+fromEscherichia+coli.">Global proteomic profiling of native outer membrane vesicles derived fromEscherichia coli.</a> Proteomics. 7, 3143-3153 (2007).</li><li>Alves, N. J., Turner, K. B., Medintz, I. L., Walper, S. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protecting+enzymatic+function+through+directed+packaging+into+bacterial+outer+membrane+vesicles.">Protecting enzymatic function through directed packaging into bacterial outer membrane vesicles.</a> Sci. Rep. 6, 24866 (2016).</li><li>Alves, N. J., Turner, K. B., Medintz, I. L., Walper, S. A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Emerging+therapeutic+delivery+capabilities+and+challenges+utilizing+enzyme/protein+packaged+bacterial+vesicles.">Emerging therapeutic delivery capabilities and challenges utilizing enzyme/protein packaged bacterial vesicles.</a> Ther. Delivery. 6, 873-887 (2015).</li></ol>

החוקרים אין לי מה לחשוף.

פונקציות פרוטוקול זה להפגין נציג מכוון טכניקת אריזה שבה אנזים עניין מיוצר וארוז לתוך OMV ידי E. coli. כמו עם טכניקות מורכבות רבות ישנם אזורים מרובים, בם הפרוטוקול יכול להיות שונה כדי להתאים לשימוש ביישומים ייחודיים שונים, שחלקם מפורטים להלן. בעוד מנגנון של אנקפסולצי...

אנו מציגים כאן שיטה בעיצוב, ייצור, וטיהור של שלפוחית ​​הממברנה החיצונית חיידקי טעון אנזים (OMV). OMV הם קטנים, בעיקר unilamellar, proteoliposomes כי טווח בגודל 30-200 1,2 ננומטר. כל חיידקים גראם-שליליים גראם חיוביים כי נחקרו עד כה הוכיחו שחרור או OMV או שלפוחית תאיים (EV) מפני השטח שלהם 3,4. המנגנון המדויק שבו OMV מיוצר עדיין הובהר באופן מלא בשל אוכלוסיות חיידקים המגוונות אשר מפרישות אותם כמו גם את הפונקציות השונות, כי הם משרתים. OMV הוכח להובלת מגוון רחב של מטענים ממולקולות קטנות, פפטידים, חלבונים ו החומר גנטי מגיש מגוון רחב של איתות מורכבת, טרנסלוקציה גן, ארסיות מתפקדת 5,6. המנגנונים המדויקים של biogenesis OMV אינם מתאפיינים היטב, נראים שונה בין מינים של חיידקים. למרות תיהים למעשה, פתחנו שיטה לשיפור יעיל האריזה של חלבון רקומביננטי לתוך OMV ידי יצירת הצמדה סינטתית בין חלבון של עניין וכן אנדוגני חלבון הנפוץ ביותר בקרום החיצוני חיידקי OMV שלאחר מכן. בהיעדר זיקה סינטתית, או זיקה שולבה באופן מלאכותי, בין חלבון recombinantly הביע ואת OMV את יעילות האריזה הנצפית היא מאוד נמוכה 7. תוצאה זו היא צפויה כמו שילוב של חלבונים בתוך OMV גם מתרחשת דרך אנקפסולציה מקריות בדיוק ברגע של היווצרות OMV על פני השטח חיידקי או באמצעות אריזות בבימויו של המנגנונים אינם מובנים היטב. חלק ההצלחה נצפתה חלבוני אריזה פשוט דרך על ביטוי במרחב periplasmic המסתמך על אנקפסולציה מקרית אלא אריזה יעילה מאוד חלבון תלוי עם כמה חלבוני אריזה ביעילות גבוהה בהשוואה לאחרים הב- אינו לארוז בכלל 8-10. על ידי ניצול טכניקות ביולוגיה סינטתית משותפות חפשנו להנדס Escherichia coli (E. coli) לייצר בו זמנית, חבילה ומפרישי אנזים פעיל עניין לתוך OMV עוקף מגבלות ידע קיימות לגבי איך OMV נוצרת וכיצד מטען נבחר על-ידי החיידקים אריזה. לעניין יישום זה מערכת bioconjugation חלבון פיצול נבחרת ההצמדה הסינטתית בחירה כדי להקל אריזה כיוונית לתוך OMV. כפי שהשם מרמז מערכת bioconjugation חלבון פיצול מורכבת משני תחומים למקטע ומשלימים אינטראקציה זה עם זה. תחומי חלבון הפיצול שנבחרו לצורך פרוטוקול זה המכונה SpyCatcher (SC) ואת SpyTag (ST) התחום נגזרים פיברונקטין מחייב pyogenes סטרפטוקוקוס החלבון (FbaB) 11. מערכת חלבון פיצול זה הוא יוצא דופן בכך wתרנגולת שתי יחידות המשנה הן בתוך קרבת אג&quot;ח isopeptide יוצרת באופן ספונטני בין הפרוקסימלי אספרטית שאריות חומצת חומצה ליזין אמינו יצירת הצמדה קוולנטי. היווצרות קשר Isopeptide אינה דורשת תוספת של חלבונים מלווים, אנזימים קטליטי, או קו-פקטורים ויכולה להתרחש בקלות בטמפרטורת חדר (RT) על פני טווח רחב של מצבים רלוונטיים מבחינה הפיזיולוגית 12. כהוכחה מושג, phosphotriesterase (PTE) (EC 3.1.8.1) מ diminuta Brevundimonas נבחרה להיות ארוז לתוך E. coli נגזר OMV 13. PTE מכיל אתר binuclear Zn / Zn פעיל ויש לו את היכולת לשבור זרחנים אורגניים באמצעות תגובה הידרוליזה המרת aryldialkylphosphates לתוך dialkylphosphates ו כהלים aryl 14. חשיפה זרחנים אורגניים פוגעת בתפקוד העצבי הנכון דרך עיכוב הידרוליזה של אצטילכולין על ידי האצטילכולין בצמתים neuromuscular מאקיןתרכובות organophosphate נגזר g 15 מסוכן מאוד. ממושך או חשיפה משמעותית זרחנים אורגניים תוצאות נפוצות עוויתות בלתי נשלטת בדרך כלל גורם למוות באמצעות מחנק. בעוד PTE מציג את הפעילות הקטליטית הגבוהה ביותר כלפי paraoxon, דברה חזקה מאוד, הוא גם מסוגל hydrolyzing מגוון רחב של חומרי הדברה אחרות ו- V / G סוג גזי עצבים כימיים 16. כדי להקל על אריזת OMV, פלסמיד חיידקי תוכנן מקודד מבנה גן המכיל מקדם מושרה, רצף לוקליזציה periplasmic, ואתר שיבוט מרובה קצר במעלה זרם של רצף גן SC. החדרה של גן PTE בין מנהיג רצף SC מותר ליצירת מתג גנטי שמכוון את חלבון היתוך PTE-SC למרחב periplasmic לאריזת OMV. למרות שהמאמצים המתוארים כאן להתמקד PTE, גן האנזים הוא להחלפה יכול להיות מוחלף בקלות עם רצף גן אחר facאריזת ilitate של אנזים או חלבון חלופי. כמו החלק השני של ההצמדה הסינטתית, חלבון הממברנה חיצוני בשפע (OmpA) נבחר להציג את רצף הפפטיד ST. בעוד הבחירה של חלבון עוגן יכול להשתנות, זה הכרחי כי החלבון יש דומיין מתירנית המציג במרחב periplasmic, סובל את ההיתוך לבנות ללא גרימת cytotoxicity, ידוע להיות נוכח OMV, ואינו מצטבר כאשר הוא recombinantly מיוצר. OmpA הוא חלבון 37.2 kDa הטרנסממברני Porin כי ידוע להיות מבוטא בכמות גבוהה בקרום החיצוני בקטריאלי ולאחר OMV 17. הוא מעורב התחבורה של מולקולות קטנות, &lt;2 ננומטר בגודל, דרך הממברנה בקטריאלי 18. יש Native OmpA שני תחומים ייחודיים מבחינה מבנית, מוטיב חבית בטא הטרנסממברני וחלק periplasmically מסיס בטרמינל C-ידוע אינטראקציה עם 19 פפטידוגליקן. בשנות ה designe היתוך OmpA-ST מוטציהד כאן חלק מסוף-C של OmpA נמחק ואת ST היה התמזג N- periplasmically פונה או C-Termini. מחיקת חלק periplasmic של OmpA מקטינה את מספר האינטראקציות בין הממברנה החיצונית ואת פפטידוגליקן וכתוצאה מכך יציבות הממברנה מובילה Hyper-vesiculation 7. הגנום OmpA נשמרה בנוסף לבנות OmpA-ST הביע recombinantly להמתיק יציבות הממברנה ברוטו.

<table><tbody><tr><td>IPTG</td><td>Any</td><td></td><td>Always prepare fresh or aliquot and freeze.</td></tr><tr><td>L-arabinose</td><td>Any</td><td></td><td>Can be prepared ahead of time and stored at 4 &amp;deg;C.</td></tr><tr><td>Ampicillin</td><td>Any</td><td></td><td>Add immediately prior to use after media cools sufficiently from being autoclaved.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>Chloramphenicol&amp;nbsp;</td><td>Any</td><td></td><td>Add immediately prior to use after media cools sufficiently from being autoclaved.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>TB/LB Culture Media</td><td>Any</td><td></td><td>Other growth medias will likely work similarly.</td></tr><tr><td>Triton X-100</td><td>Any</td><td></td><td>One of many potential suitable surfactants.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>Baffled culture flasks</td><td>Any</td><td></td><td>The baffles promote higher levels of aeration.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>CHES</td><td>Fisher Bioreagents</td><td>BP318-100</td><td>Optimal buffer used for paraoxon degredation (pH &gt; 8).</td></tr><tr><td>Paraoxon</td><td>Chem Service</td><td>N-12816</td><td>Very toxic substance to be handled carefully and disposed of properly.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>Syringe Filter 0.45 &amp;micro;m</td><td>Thermo Scientific</td><td>60183-221 (30 mm)</td><td>Filter diameter will depend on volume of sample. Low protein binding membrane is critical.</td></tr><tr><td>Shaker incubator</td><td>New Brunswick</td><td>Excella E24</td><td>Precise temperature and mixing is essential for reproducable bacterial growth.&amp;nbsp;</td></tr><tr><td>Sorvall Culture Centrifuge</td><td>Thermo Scientific</td><td>RC 5B PLUS</td><td>Large volume (500 ml) culture centrifuge capable of 7,000 x g.</td></tr><tr><td>Sorvall Ultracentrifuge&amp;nbsp;</td><td>Thermo Scientific</td><td>WX Ultra 90</td><td>Capable of centrifugal forces &amp;ge;150,000 x g.</td></tr><tr><td>Ultracentrifuge Rotor</td><td>Thermo Scientific</td><td>AH-629</td><td>Ensure the proper rotor and tubes are used and that everything is properly balanced.</td></tr><tr><td>Ultra-Clear Ultracentrifuge Tubes (25 x 89 mm)</td><td>Beckman Coulter</td><td>344058</td><td>Ensure no stress fractures are present prior to use and that tubes are presicely balanced.</td></tr><tr><td>Spectrophotometer&amp;nbsp;</td><td>Tecan</td><td>Infinite M1000</td><td>Necessary for enzyme kinetic assays.</td></tr><tr><td>DLS/particle tracking</td><td>NanoSight&amp;nbsp;</td><td>LM10</td><td>Necessary for OMV size distribution and concentration determination.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>BL21(DE3)</td><td>NEB</td><td></td><td>Suitable bacterial expression strain.</td></tr><tr><td>pET22</td><td>EMD Millipore</td><td>69744-3</td><td>Other plasmids can be used in place of these.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>pACYC184</td><td>NEB</td><td></td><td>Other plasmids can be used in place of these.&amp;nbsp;&amp;nbsp;</td></tr><tr><td>Gel Extraction Kit</td><td>Qiagen</td><td>28704</td><td>Example kit.</td></tr></tbody></table>

directed protein packaging within outer membrane vesicles from escherichia coli: design, production and purification

עניין גובר יישום טכניקות ביולוגיה סינטטיות לתכנת שלפוחית ​​קרום חיצונית (OMV) מוביל כמה יישומים מעניינים וייחודיים מאוד עבור OMV שבו חלקיקים מסורתיים מוכיחים קשים מדי לסנתז. נכון להיום, כל חיידקים גראם שליליים הוכחו לייצר אריזות הוכחת OMV של מגוון מטענים הכוללת מולקולות קטנות, פפטידים, חלבונים החומר הגנטי. בהתבסס על המטענים המגוונים שלהם, OMV הם מעורבים בתהליכים ביולוגיים רבים, החלו מתקשורת תאי תאים כדי העברת גנים ואספקה ​​של גורמים ארסיים התלויים בו חיידקים מפיקים את OMV. רק לאחרונה חיידקי OMV להיות נגיש לשימוש על פני מגוון רחב של יישומים באמצעות פיתוח טכניקות לשלוט ואריזה ישירה של חלבונים רקומביננטיים לתוך OMV. פרוטוקול זה מתאר שיטה לייצור, טיהור, ושימוש OMV ארוז אנזים מתן השתפר overaייצור ll של אנזים רקומביננטי, vesiculation גדל, ויציבות אנזים משופר. ניצול מוצלח של פרוטוקול זה יגרום ליצירת זן חיידקים אשר בו זמנית מייצר חלבון רקומביננטי ומפנה אותו אנקפסולציה OMV באמצעות יצירת זיקה סינטתית בין חלבון רקומביננטי חלבון עוגן הממברנה חיצוני. גם פרוטוקול זה מפרט שיטות לבידוד OMV מתרבויות חיידקים כמו גם טכניקות טיפול הולמות ודברים שיש להביא בחשבון בעת ​​התאמת פרוטוקול זה לשימוש עבור יישומים ייחודיים אחרים כגון: משלוח סמי תרופות, אבחון רפואי, וטיפול סביבתי.

ביטוי סימולטני של שני חלבונים רקומביננטיים, כפי שנדרש לצורך אסטרטגית אריזת OMV המפורטים בפרוטוקול זה, ניתן להשיג באמצעות מספר דרכים שונות. כאן, מערכת וקטור שני נוצלה עם מקורותיה התואמים של שכפול קלטות גן מושרים נפרדות. על מנת לתת הביטוי של PTE-SC לבנות ע...

Watch this Scientific Journal Video about Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification at JoVE.com

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

A protocol for the production, purification, and use of enzyme packaged outer membrane vesicles (OMV) providing for enhanced enzyme stability for implementation across diverse applications is presented.

אריזת חלבון בימוי בתוך החיצון ממברנה השלפוחית ​​מ<em&gt; Coli Escherichia</em&gt;: עיצוב, ייצור טיהור

An increasing interest in applying synthetic biology techniques to program outer membrane vesicles (OMV) are leading to some very interesting and unique ...

directed-protein-packaging-within-outer-membrane-vesicles-from

Universidad de Cartagena UDEC

Research

JoVE Journal

Biochemistry

Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

13.3K Views.  Naval Research Laboratory. A protocol for the production, purification, and use of enzyme packaged outer membrane vesicles (OMV) providing for enhanced enzyme stability for implementation across diverse applications is presented. 

Video: Directed Protein Packaging within Outer Membrane Vesicles from Escherichia coli: Design, Production and Purification

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD

New therapies are needed to treat Clostridium difficile infections that are a major threat to human health. The C. difficile metalloprotease PPEP-1 is a target for future development of inhibitors to decrease the virulence of the pathogen. To perform biophysical and structural characterization as well as inhibitor screening, large amounts of pure and active protein will be needed. We have developed a protocol for efficient production and purification of PPEP-1 by the use of E. coli as the expression host yielding sufficient amounts and purity of protein for crystallization and structure determination. Additionally, using microseeding, highly intergrown crystals of PPEP-1 can be grown to well-ordered crystals suitable for X-ray diffraction analysis. The methods could also be used to produce other recombinant proteins and to study the structures of other proteins producing intergrown crystals.

Production, Crystallization and Structure Determination of C. difficile PPEP-1 via Microseeding and Zinc-SAD

Proline-proline endopeptidase-1 (PPEP-1) is a secreted metalloprotease and promising drug-target from the human pathogen Clostridium difficile. Here we describe all methods necessary for the production and structure determination of this protein.

הפקה, התגבשות וקביעת מבנה<em&gt; C. difficile</em&gt; PPEP-1 באמצעות Microseeding ואבץ-SAD

New therapies are needed to treat Clostridium difficile infections that are a major threat to human health. The C. difficile metalloprotease PPEP-1 is a ...

From Constructs to Crystals &#8211; Towards Structure Determination of &#946;-barrel Outer Membrane Proteins

Membrane proteins serve important functions in cells such as nutrient transport, motility, signaling, survival and virulence, yet constitute only ~1% percent of known structures. There are two types of membrane proteins, &#945;-helical and &#946;-barrel. While &#945;-helical membrane proteins can be found in nearly all cellular membranes, &#946;-barrel membrane proteins can only be found in the outer membranes of mitochondria, chloroplasts, and Gram-negative bacteria. One common bottleneck in structural studies of membrane proteins in general is getting enough pure sample for analysis. In hopes of assisting those interested in solving the structure of their favorite &#946;-barrel outer membrane protein (OMP), general protocols are presented for the production of target &#946;-barrel OMPs at levels useful for structure determination by either X-ray crystallography and/or NMR spectroscopy. Here, we outline construct design for both native expression and for expression into inclusion bodies, purification using an affinity tag, and crystallization using detergent screening, bicelle, and lipidic cubic phase techniques. These protocols have been tested and found to work for most OMPs from Gram-negative bacteria; however, there are some targets, particularly for mitochondria and chloroplasts that may require other methods for expression and purification. As such, the methods here should be applicable for most projects that involve OMPs from Gram-negative bacteria, yet the expression levels and amount of purified sample will vary depending on the target OMP.

&#946;-barrel outer membrane proteins (OMPs) serve many functions within the outer membranes of Gram-negative bacteria, mitochondria, and chloroplasts. Here, we hope to alleviate a known bottleneck in structural studies by presenting protocols for the production of &#946;-barrel OMPs in sufficient quantities for structure determination by X-ray crystallography or NMR spectroscopy.

מתוך בונה קריסטלים - לקראת מבנה קביעת β-חבית החיצון ממברנה חלבונים

Membrane proteins serve important functions in cells such as nutrient transport, motility, signaling, survival and virulence, yet constitute only ~1% ...

Chemistry

Method for Efficient Refolding and Purification of Chemoreceptor Ligand Binding Domain

Identification of natural ligands of chemoreceptors and structural studies aimed at elucidation of the molecular basis of the ligand specificity can be greatly facilitated by the production of milligram amounts of pure, folded ligand binding domains. Attempts to heterologously express periplasmic ligand binding domains of bacterial chemoreceptors in Escherichia coli (E. coli) often result in their targeting into inclusion bodies. Here, a method is presented for protein recovery from inclusion bodies, its refolding and purification, using the periplasmic dCACHE ligand binding domain of Campylobacter jejuni (C. jejuni) chemoreceptor Tlp3 as an example. The approach involves expression of the protein of interest with a cleavable His6-tag, isolation and urea-mediated solubilisation of inclusion bodies, protein refolding by urea depletion, and purification by means of affinity chromatography, followed by tag removal and size-exclusion chromatography. The circular dichroism spectroscopy is used to confirm the folded state of the pure protein. It has been demonstrated that this protocol is generally useful for production of milligram amounts of dCACHE periplasmic ligand binding domains of other bacterial chemoreceptors in a soluble and crystallisable form.

A procedure is presented for the refolding of the dCACHE periplasmic ligand binding domain of Campylobacter jejuni chemoreceptor Tlp3 from inclusion bodies and the purification to yield milligram quantities of protein.

שיטת Refolding יעילה וטיהור של ליגנד Chemoreceptor מחייב תחום

Identification of natural ligands of chemoreceptors and structural studies aimed at elucidation of the molecular basis of the ligand specificity can be ...

Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles

Several methods have been developed to functionally characterize novel membrane transporters. Polyamines are ubiquitous in all organisms, but polyamine exchangers in plants have not been identified. Here, we outline a method to characterize polyamine antiporters using membrane vesicles generated from the lysis of Escherichia coli cells heterologously expressing a plant antiporter. First, we heterologously expressed AtBAT1 in an E. coli strain deficient in polyamine and arginine exchange transporters. Vesicles were produced using a French press, purified by ultracentrifugation and utilized in a membrane filtration assay of labeled substrates to demonstrate the substrate specificity of the transporter. These assays demonstrated that AtBAT1 is a proton-mediated transporter of arginine, &#947;-aminobutyric acid (GABA), putrescine and spermidine. The mutant strain that was developed for the assay of AtBAT1 may be useful for the functional analysis of other families of plant and animal polyamine exchangers. We also hypothesize that this approach can be used to characterize many other types of antiporters, as long as these proteins can be expressed in the bacterial cell membrane. E. coli is a good system for the characterization of novel transporters, since there are multiple methods that can be employed to mutagenize native transporters.

Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles

We describe a method for the characterization of proton-driven membrane transporters in membrane vesicle preparations produced by heterologous expression in E. coli and lysis of cells using a French press.

אפיון מובילי הממברנה על ידי ביטוי הטרוולוגי ב -E. coli וייצור ממברנה ושלפוחיות

Several methods have been developed to functionally characterize novel membrane transporters. Polyamines are ubiquitous in all organisms, but polyamine ...

Design and Construction of Artificial Extracellular Matrix (aECM) Proteins from Escherichia coli for Skin Tissue Engineering

Recombinant technology is a versatile platform to create novel artificial proteins with tunable properties. For the last decade, many artificial proteins that have incorporated functional domains derived from nature (or created de novo) have been reported. In particular, artificial extracellular matrix (aECM) proteins have been developed; these aECM proteins consist of biological domains taken from fibronectin, laminins and collagens and are combined with structural domains including elastin-like repeats, silk and collagen repeats. To date, aECM proteins have been widely investigated for applications in tissue engineering and wound repair. Recently, Tjin and coworkers developed integrin-specific aECM proteins designed for promoting human skin keratinocyte attachment and propagation. In their work, the aECM proteins incorporate cell binding domains taken from fibronectin, laminin-5 and collagen IV, as well as flanking elastin-like repeats. They demonstrated that the aECM proteins developed in their work were promising candidates for use as substrates in artificial skin. Here, we outline the design and construction of such aECM proteins as well as their purification process using the thermo-responsive characteristics of elastin.

Design and Construction of Artificial Extracellular Matrix aECM Proteins from Escherichia coli for Skin Tissue Engineering

Recombinant technologies have enabled material designers to create novel artificial proteins with customized functionalities for tissue engineering applications. For example, artificial extracellular matrix proteins can be designed to incorporate structural and biological domains derived from native ECMs. Here, we describe the construction and purification of aECM proteins containing elastin-like repeats.

עיצוב ובנייה של תאי מטריקס המלאכותי (aECM) חלבונים מ<em&gt; Coli Escherichia</em&gt; להנדסת רקמות עור

Recombinant technology is a versatile platform to create novel artificial proteins with tunable properties. For the last decade, many artificial proteins ...

Bioengineering

Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

Over the last 50 years, Cell-Free Protein Synthesis (CFPS) has emerged as a powerful technology to harness the transcriptional and translational capacity of cells within a test tube. By obviating the need to maintain the viability of the cell, and by eliminating the cellular barrier, CFPS has been foundational to emerging applications in biomanufacturing of traditionally challenging proteins, as well as applications in rapid prototyping for metabolic engineering, and functional genomics. Our methods for implementing an E. coli-based CFPS platform allow new users to access many of these applications. Here, we describe methods to prepare extract through the use of enriched media, baffled flasks, and a reproducible method of tunable sonication-based cell lysis. This extract can then be used for protein expression capable of producing 900 &#181;g/mL or more of super folder green fluorescent protein (sfGFP) in just 5 h from experimental setup to data analysis, given that appropriate reagent stocks have been prepared beforehand. The estimated startup cost of obtaining reagents is $4,500 which will sustain thousands of reactions at an estimated cost of $0.021 per &#181;g of protein produced or $0.019 per &#181;L of reaction. Additionally, the protein expression methods mirror the ease of the reaction setup seen in commercially available systems due to optimization of reagent pre-mixes, at a fraction of the cost. In order to enable the user to leverage the flexible nature of the CFPS platform for broad applications, we have identified a variety of aspects of the platform that can be tuned and optimized depending on the resources available and the protein expression outcomes desired.

Escherichia coli-Based Cell-Free Protein Synthesis: Protocols for a robust, flexible, and accessible platform technology

This protocol details the steps, costs, and equipment necessary to generate E. coli-based cell extracts and implement in vitro protein synthesis reactions within 4 days or less. To leverage the flexible nature of this platform for broad applications, we discuss reaction conditions that can be adapted and optimized.

Escherichia coli-המבוסס על סינתזת החלבון ללא תא: פרוטוקולים עבור טכנולוגיית פלטפורמה חזקים, גמישים ונגישים

Over the last 50 years, Cell-Free Protein Synthesis (CFPS) has emerged as a powerful technology to harness the transcriptional and translational capacity ...

Directed Assembly of Elastin-like Proteins into defined Supramolecular Structures and Cargo Encapsulation In Vitro

Tailored proteinaceous building blocks are versatile candidates for the assembly of supramolecular structures such as minimal cells, drug delivery vehicles and enzyme scaffolds. Due to their biocompatibility and tunability on the genetic level, Elastin-like proteins (ELP) are ideal building blocks for biotechnological and biomedical applications. Nevertheless, the assembly of protein based supramolecular structures with distinct physiochemical properties and good encapsulation potential remains challenging.
Here we provide two efficient protocols for guided self-assembly of amphiphilic ELPs into supramolecular protein architectures such as spherical coacervates, fibers and stable vesicles. The presented assembly protocols generate Protein Membrane-Based Compartments (PMBCs) based on ELPs with adaptable physicochemical properties. PMBCs demonstrate phase separation behavior and reveal method dependent membrane fusion and are able to encapsulate chemically diverse fluorescent cargo molecules. The resulting PMBCs have a high application potential as a drug formulation and delivery platform, artificial cell, and compartmentalized reaction space.

At the interface of organic and aqueous solvents, tailored amphiphilic elastin-like proteins assemble into complex supramolecular structures such as vesicles, fibers and coacervates triggered by environmental parameters. The described assembly protocols yield Protein Membrane-Based Compartments (PMBCs) with tunable properties, enabling the encapsulation of various cargo.

בימוי האסיפה של אלסטין כמו חלבונים לתוך הגדרת מבנים Supraולקולריים מוגדרים מחוץ לגופית

Tailored proteinaceous building blocks are versatile candidates for the assembly of supramolecular structures such as minimal cells, drug delivery ...

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Since most cellular processes are mediated by macromolecular assemblies, the systematic identification of protein-protein interactions (PPI) and the identification of the subunit composition of multi-protein complexes can provide insight into gene function and enhance understanding of biological systems1, 2. Physical interactions can be mapped with high confidence vialarge-scale isolation and characterization of endogenous protein complexes under near-physiological conditions based on affinity purification of chromosomally-tagged proteins in combination with mass spectrometry (APMS). This approach has been successfully applied in evolutionarily diverse organisms, including yeast, flies, worms, mammalian cells, and bacteria1-6. In particular, we have generated a carboxy-terminal Sequential Peptide Affinity (SPA) dual tagging system for affinity-purifying native protein complexes from cultured gram-negative Escherichia coli, using genetically-tractable host laboratory strains that are well-suited for genome-wide investigations of the fundamental biology and conserved processes of prokaryotes1, 2, 7. Our SPA-tagging system is analogous to the tandem affinity purification method developed originally for yeast8, 9, and consists of a calmodulin binding peptide (CBP) followed by the cleavage site for the highly specific tobacco etch virus (TEV) protease and three copies of the FLAG epitope (3X FLAG), allowing for two consecutive rounds of affinity enrichment. After cassette amplification, sequence-specific linear PCR products encoding the SPA-tag and a selectable marker are integrated and expressed in frame as carboxy-terminal fusions in a DY330 background that is induced to transiently express a highly efficient heterologous bacteriophage lambda recombination system10. Subsequent dual-step purification using calmodulin and anti-FLAG affinity beads enables the highly selective and efficient recovery of even low abundance protein complexes from large-scale cultures. Tandem mass spectrometry is then used to identify the stably co-purifying proteins with high sensitivity (low nanogram detection limits).
Here, we describe detailed step-by-step procedures we commonly use for systematic protein tagging, purification and mass spectrometry-based analysis of soluble protein complexes from E. coli, which can be scaled up and potentially tailored to other bacterial species, including certain opportunistic pathogens that are amenable to recombineering. The resulting physical interactions can often reveal interesting unexpected components and connections suggesting novel mechanistic links. Integration of the PPI data with alternate molecular association data such as genetic (gene-gene) interactions and genomic-context (GC) predictions can facilitate elucidation of the global molecular organization of multi-protein complexes within biological pathways. The networks generated for E. coli can be used to gain insight into the functional architecture of orthologous gene products in other microbes for which functional annotations are currently lacking.

Identification of Protein Complexes in Escherichia coli using Sequential Peptide Affinity Purification in Combination with Tandem Mass Spectrometry

Affinity purification of tagged proteins in combination with mass spectrometry (APMS) is a powerful method for the systematic mapping of protein interaction networks and for investigating the mechanistic basis of biological processes. Here, we describe an optimized sequential peptide affinity (SPA) APMS procedure developed for the bacterium Escherichia coli that can be used to isolate and characterize stable multi-protein complexes to near homogeneity even starting from low copy numbers per cell.

זיהוי של קומפלקסי חלבונים ב<em&gt; חיידקי Escherichia</em&gt; באמצעות טיהור זיקת פפטיד סדרתית בשילוב עם טנדם המוני ספקטרומטריית

Since most cellular processes are mediated by macromolecular assemblies, the systematic identification of protein-protein interactions (PPI) and the ...

Biology

Production and Visualization of Bacterial Spheroplasts and Protoplasts to Characterize Antimicrobial Peptide Localization

The use of confocal microscopy as a method to assess peptide localization patterns within bacteria is commonly inhibited by the resolution limits of conventional light microscopes. As the resolution for a given microscope cannot be easily enhanced, we present protocols to transform the small rod-shaped gram-negative Escherichia coli (E. coli) and gram-positive Bacillus megaterium (B. megaterium) into larger, easily imaged spherical forms called spheroplasts or protoplasts. This transformation allows observers to rapidly and clearly determine whether peptides lodge themselves into the bacterial membrane (i.e., membrane localizing) or cross the membrane to enter the cell (i.e., translocating). With this approach, we also present a systematic method to characterize peptides as membrane localizing or translocating. While this method can be used for a variety of membrane-active peptides and bacterial strains, we demonstrate the utility of this protocol by observing the interaction of Buforin II P11A (BF2 P11A), an antimicrobial peptide (AMP), with E. coli spheroplasts and B. megaterium protoplasts.

Here we present a protocol to produce gram-negative Escherichia coli (E. coli) spheroplasts and gram-positive Bacillus megaterium (B. megaterium) protoplasts to clearly visualize and rapidly characterize peptide-bacteria interactions. This provides a systematic method to define membrane localizing and translocating peptides.

ייצור והדמיה של חיידקי Spheroplasts ו- Protoplasts כדי לאפיין פפטיד מיקרוביאלית לוקליזציה

The use of confocal microscopy as a method to assess peptide localization patterns within bacteria is commonly inhibited by the resolution limits of ...

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Diverse bacterial species secrete ~20-300 nm extracellular vesicles (EVs), comprised of lipids, proteins, nucleic acids, glycans, and other molecules derived from the parental cells. EVs function as intra- and inter-species communication vectors while also contributing to the interaction between bacteria and host organisms in the context of infection and colonization. Given the multitude of functions attributed to EVs in health and disease, there is a growing interest in isolating EVs for in vitro and in vivo studies. It was hypothesized that the separation of EVs based on physical properties, namely size, would facilitate the isolation of vesicles from diverse bacterial cultures. 
The isolation workflow consists of centrifugation, filtration, ultrafiltration, and size-exclusion chromatography (SEC) for the isolation of EVs from bacterial cultures. A pump-driven tangential flow filtration (TFF) step was incorporated to enhance scalability, enabling the isolation of material from liters of starting cell culture. Escherichia coli was used as a model system expressing EV-associated nanoluciferase and non-EV-associated mCherry as reporter proteins. The nanoluciferase was targeted to the EVs by fusing its N-terminus with cytolysin A. Early chromatography fractions containing 20-100 nm EVs with associated cytolysin A - nanoLuc were distinct from the later fractions containing the free proteins. The presence of EV-associated nanoluciferase was confirmed by immunogold labeling and transmission electron microscopy. This EV isolation workflow is applicable to other human gut-associated gram-negative and gram-positive bacterial species. In conclusion, combining centrifugation, filtration, ultrafiltration/TFF, and SEC enables scalable isolation of EVs from diverse bacterial species. Employing a standardized isolation workflow will facilitate comparative studies of microbial EVs across species.

Scalable Isolation and Purification of Extracellular Vesicles from Escherichia coli and Other Bacteria

Bacteria secrete nanometer-sized extracellular vesicles (EVs) carrying bioactive biological molecules. EV research focuses on understanding their biogenesis, role in microbe-microbe and host-microbe interactions and disease, as well as their potential therapeutic applications. A workflow for scalable isolation of EVs from various bacteria is presented to facilitate standardization of EV research.

בידוד וטיהור מדרגיים של שלפוחיות חוץ-תאיות מ-Escherichia coli וחיידקים אחרים

Diverse bacterial species secrete ~20-300 nm extracellular vesicles (EVs), comprised of lipids, proteins, nucleic acids, glycans, and other molecules ...

אריזת חלבון בימוי בתוך החיצון ממברנה השלפוחית מ

Summary

Explore More Videos

Chapters in this video

הפקה, התגבשות וקביעת מבנה

מתוך בונה קריסטלים - לקראת מבנה קביעת β-חבית החיצון ממברנה חלבונים

שיטת Refolding יעילה וטיהור של ליגנד Chemoreceptor מחייב תחום

אפיון מובילי הממברנה על ידי ביטוי הטרוולוגי ב -E. coli וייצור ממברנה ושלפוחיות

עיצוב ובנייה של תאי מטריקס המלאכותי (aECM) חלבונים מ

Escherichia coli-המבוסס על סינתזת החלבון ללא תא: פרוטוקולים עבור טכנולוגיית פלטפורמה חזקים, גמישים ונגישים

בימוי האסיפה של אלסטין כמו חלבונים לתוך הגדרת מבנים Supraולקולריים מוגדרים מחוץ לגופית

זיהוי של קומפלקסי חלבונים ב

ייצור והדמיה של חיידקי Spheroplasts ו- Protoplasts כדי לאפיין פפטיד מיקרוביאלית לוקליזציה

בידוד וטיהור מדרגיים של שלפוחיות חוץ-תאיות מ-Escherichia coli וחיידקים אחרים

אריזת חלבון בימוי בתוך החיצון ממברנה השלפוחית ​​מ

Summary

Explore More Videos

Chapters in this video

הפקה, התגבשות וקביעת מבנה

מתוך בונה קריסטלים - לקראת מבנה קביעת β-חבית החיצון ממברנה חלבונים

שיטת Refolding יעילה וטיהור של ליגנד Chemoreceptor מחייב תחום

אפיון מובילי הממברנה על ידי ביטוי הטרוולוגי ב -E. coli וייצור ממברנה ושלפוחיות

עיצוב ובנייה של תאי מטריקס המלאכותי (aECM) חלבונים מ

Escherichia coli-המבוסס על סינתזת החלבון ללא תא: פרוטוקולים עבור טכנולוגיית פלטפורמה חזקים, גמישים ונגישים

בימוי האסיפה של אלסטין כמו חלבונים לתוך הגדרת מבנים Supraולקולריים מוגדרים מחוץ לגופית

זיהוי של קומפלקסי חלבונים ב

ייצור והדמיה של חיידקי Spheroplasts ו- Protoplasts כדי לאפיין פפטיד מיקרוביאלית לוקליזציה

בידוד וטיהור מדרגיים של שלפוחיות חוץ-תאיות מ-Escherichia coli וחיידקים אחרים

אריזת חלבון בימוי בתוך החיצון ממברנה השלפוחית מ